Login to Your Account

Mirna, Marina Weigh Anchor for MicroRNA Delivery Partnership

By Catherine Shaffer
BioWorld Today Contributing Writer

Wednesday, December 28, 2011
Mirna Therapeutics Inc. will be using Smarticles liposomal delivery technology developed by Marina Biotech Inc. under a new license agreement worth $63 million up front and in milestones, plus royalties on product sales.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription